S447X polymorphism in the lipoprotein lipase gene and the adiponectin level in the general population: Results from the mima study

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 3, 2009, Pages 188-193

  Fujiwara, Shinji ^a,b   Kotani, Kazuhiko ^b,c   Sano, Yoshiko ^c   Matsuoka, Yukiyo ^c   Tsuzaki, Kokoro ^c   Domichi, Masayuki ^c   Kajii, Eiji ^b   Sakane, Naoki ^c  

^a Mima City National Health Insurance Koyadaira Clinic   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Adipocytokine; Association study; HDL cholesterol; Lipid metabolism

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; PRIMER DNA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

EID: 70350218743     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E593     Document Type: Article

References (32)

1. Goldberg IJ: Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res, 1996; 37:693-707
2. Assmann G, Betteridge DJ, Gotto AM Jr, Steiner G: Management of hypertriglyceridemic patients. A. Treatment classifications and goals. Am J Cardiol, 1991; 68:30A-34A
3. Murthy V, Julien P, Gagne C: Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther, 1996; 70:101-135
4. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG: Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation, 1999; 99:2901-2907
5. Miller M, Zhan M: Genetic determinants of low high-density lipoprotein cholesterol. Curr Opin Cardiol, 2004; 19:380-384
6. Boekholdt SM, Souverein OW, Tanck MW, Hovingh GK, Kuivenhoven JA, Peters RI, Jansen H, Schiffers PM, van der Wall EE, Doevendans PA, Reitsma PH, Zwinderman AH, Kastelein JJ, Jukema JW: Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels. Clin Genet, 2006; 69:263-270
7. Sviridov D, Nestel PJ: Genetic factors affecting HDL levels, structure, metabolism and function. Curr Opin Lipidol, 2007; 18:157-163
8. Stocks J, Thorn JA, Galton DJ: Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res, 1992; 33:853-857
9. Hata A, Robertson M, Emi M, Lalouel JM: Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res, 1990; 18:5407-5411
10. Rip J, Nierman MC, Ross CJ, Jukema JW, Hayden MR, Kastelein JJ, Stroes ES, Kuivenhoven JA: Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol, 2006; 26:1236-1245
11. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B: Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab, 2007; 92:571-576
12. Hegener HH, Lee IM, Cook NR, Ridker PM, Zee RY: Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem, 2006; 52:2021-2027
13. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H: Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow up of a large cohort from southern Germany. J Am Coll Cardiol, 2006; 48:1369-1377
14. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH: Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation, 2006; 114:623-629
15. Menzaghi C, Trischitta V, Doria A: Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes, 2007; 56:1198-1209
16. Taskinen MR, Glueck CJ, Kashyap ML, Srivastava LS, Hynd BA, Perisutti G, Robinson K, Kinnunen PJ, Kuusi T: Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein C II in familial hyperalphalipoproteinemic and in normal subjects. Atherosclerosis, 1980; 37:247-256
17. Jackson RL, Yates MT, McNerney CA, Kashyap ML: Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Horm Metab Res, 1990; 22:289-294
18. De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP: Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clin Lab, 2005; 51:403-409
19. von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA: Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care, 2004; 27:2925-2929
20. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T: Corration of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond), 2002; 103:137-142
21. Im JA, Kim SH, Lee JW, Shim JY, Lee HR, Lee DC: Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism, 2006; 55:1546-1550
22. Altinova AE, Toruner F, Bukan N, Yasar DG, Akturk M, Cakir N, Arslan M: Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J, 2007; 54:221-226
23. Tsuzaki K, Kotani K, Fujiwara S, Sano Y, Matsuoka Y, Domichi M, Hamada T, Shimatsu A, Sakane N: The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with increased small dense low-density lipoprotein in a rural Japanese population: The Mima study. Metabolism, 2007; 56:1689-1693
24. van Bockxmeer FM, Liu Q, Mamotte C, Burke V, Taylor R: Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis, 2001; 157:123-129
25. Sing K, Ballatyne CM, Ferlic L, Brugada R, Cushman I, Dunn JK, Herd JA, Pownall HJ, Gotto AM, Marian AJ: Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis, 1999; 144:435-442
26. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Egashira T, Hattori H, Shirahashi N, Kita T: Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb, 2005; 12:240-250
27. Li J, Kondo A, Kanno T, Maekawa M: A common truncated variant of lipoprotein lipase in the Japanese population is characterized by pattern B phenotype. Clin Chem Lab Med, 2003; 41:1304-1307
28. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001; 7:941-946
29. Ong JM, Kirchgessner TG, Schotz MC, Kern PA: Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J Biol Chem, 1988; 263:12933-12938
30. Semenkovich CF, Wims M, Noe L, Etienne J, Chan L: Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and post-translational levels. J Biol Chem, 1989; 264:9030-9038
31. Ukkola O, Garenc C, Pérusse L, Bergeron J, Després JP, Rao DC, Bouchard C: Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Québec Family Study. Atherosclerosis, 2001; 158:199-206
32. Kobayashi J, Kusunoki M, Murase Y, Kawashiri M, Higashikata T, Miwa K, Katsuda S, Takata M, Asano A, Nohara A, Inazu A, Mabuchi H: Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res, 2005; 37:505-509